Taking responsibility

Scheduling decisions see migraine treatments move to Pharmacist Only status, while liquid paracetamol S2 sales to be restricted from mid-year Proposed medicines scheduling changes will see the migraine treatments Sumatriptan and Zolmatriptan move to Schedule 3 (Pharmacist Only) from early next year.  Also, there will be significant changes to sales of liquid paracetamol preparation scheduling